ArticleJournal for immunotherapy of cancer2019

Correction to: Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study.

Asim Amin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.